Some immune checkpoint inhibitors include: Pembrolizumab, or Keytruda<SUP> </SUP>. Nivolumab, or Opdivo<SUP> </SUP>. Atezolizumab, or Tecentriq<SUP> </SUP>. Ipilimumab, or Yervoy<SUP> </SUP>.